The US Food and Drug
Administration (FDA) has approved
Adynovate, antihaemophilic factor
(recombinant), PEGylated for use
in adults and adolescents, aged
12 years and older, who have
Haemophilia A.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Nov 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Nov 15
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.